"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...
Easier access to compassionate end-of-life care is now available for patients and families in Fort Worth and surrounding ...